RxNorm Semantic Concepts Index - 235
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "235".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 23520 | Deoxyribonucleic acid beta-glucosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23520 | Deoxyribonucleic acid beta-glucosyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23520 | Deoxyribonucleic acid beta-glucosyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235219 | digitalis leaves | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235219 | digitalis leaves | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235224 | terazosin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235224 | terazosin hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235224 | terazosin hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235225 | cryptenamine acetates | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235226 | cryptenamine tannates | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235228 | Dioxyline phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235228 | Dioxyline phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235229 | ethaverine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235230 | Nicardipine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235230 | Nicardipine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235230 | Nicardipine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 235230 | Nicardipine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235271 | ferrous cacodylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235272 | iron,peptonized | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235273 | Calcium iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235273 | Calcium iodide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235273 | Calcium iodide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235273 | Calcium iodide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235273 | Calcium iodide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235275 | insulin, regular, beef-pork | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235278 | insulin, protamine zinc, beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235279 | insulin, protamine zinc, pork | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235280 | lente insulin, beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235281 | ultralente insulin, beef-pork | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235282 | ultralente insulin, beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235283 | insulin, prompt zinc, beef-pork | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235284 | insulin, prompt zinc, beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235285 | insulin, prompt zinc, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235286 | insulin, prompt zinc, pork | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235288 | phenformin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2353 | Clorazepate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2353 | Clorazepate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2353 | Clorazepate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2353 | Clorazepate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2353 | Clorazepate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235350 | intrinsic factor / vitamin B12 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 235354 | nicotinyl alcohol tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235355 | Thiamin hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 235355 | Thiamin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235355 | Thiamin hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235355 | Thiamin hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235370 | Trientine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235370 | Trientine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235370 | Trientine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235373 | Difenoxin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235373 | Difenoxin hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235373 | Difenoxin hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235375 | malt extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235376 | iron bile salts | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235379 | Lipancreatin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235379 | Lipancreatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235379 | Lipancreatin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235379 | Lipancreatin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235379 | Lipancreatin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235379 | Lipancreatin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235381 | methandriol dipropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235389 | mestranol / norethynodrel | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 235398 | Oxybuprocaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235398 | Oxybuprocaine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235398 | Oxybuprocaine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 235398 | Oxybuprocaine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2354 | chlorcyclizine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 235401 | Piperocaine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235401 | Piperocaine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235402 | Cinchocaine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235402 | Cinchocaine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235402 | Cinchocaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235402 | Cinchocaine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235403 | Quinisocaine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235403 | Quinisocaine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235403 | Quinisocaine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235404 | barbital sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235408 | clorazepic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235409 | Carphenazine maleate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235409 | Carphenazine maleate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235411 | vitamin C 200 MG / Ferrous fumarate 108 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235411 | vitamin C 200 MG / Ferrous fumarate 108 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235411 | vitamin C 200 MG / Ferrous fumarate 108 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235411 | vitamin C 200 MG / Ferrous fumarate 108 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235412 | codeine polistirex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235413 | anileridine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235416 | ethoheptazine citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235418 | potassium salicylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235419 | levallorphan tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235421 | cycrimine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235422 | chlorphenoxamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235423 | zinc gluconate 35 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 235423 | zinc gluconate 35 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235424 | dimethoxanate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235426 | Pilocarpine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235426 | Pilocarpine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235426 | Pilocarpine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235428 | Homatropine hydrobromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235428 | Homatropine hydrobromide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235428 | Homatropine hydrobromide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235430 | Hexocyclium metilsulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235430 | Hexocyclium metilsulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235430 | Hexocyclium metilsulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235430 | Hexocyclium metilsulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235433 | adiphenine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235438 | Protokylol hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235438 | Protokylol hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235447 | pirbuterol HCl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235450 | Benzazoline hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 235450 | Benzazoline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235450 | Benzazoline hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235450 | Benzazoline hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235455 | sodium pyroglutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235461 | aluminum diaceate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 235461 | aluminum diaceate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 235462 | Lotio alba | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235462 | Lotio alba | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235462 | Lotio alba | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235471 | Aluminium nicotinate | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 235471 | Aluminium nicotinate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235471 | Aluminium nicotinate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235473 | Porcine heparin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235473 | Porcine heparin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235473 | Porcine heparin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235473 | Porcine heparin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235473 | Porcine heparin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235479 | thyroid, porcine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 235481 | Human calcitonin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235481 | Human calcitonin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235481 | Human calcitonin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235482 | Hydrocortisone sodium phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235482 | Hydrocortisone sodium phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235482 | Hydrocortisone sodium phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235483 | Hydrocortisone sodium succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235483 | Hydrocortisone sodium succinate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235483 | Hydrocortisone sodium succinate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235486 | Dexamethasone phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235486 | Dexamethasone phosphate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235486 | Dexamethasone phosphate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235487 | Clocortolone acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235487 | Clocortolone acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235489 | vitamin E 50 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235493 | Sodium aminobenzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235493 | Sodium aminobenzoate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235493 | Sodium aminobenzoate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235494 | potassium citrate / sodium citrate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 235496 | Sodium acid phosphate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235496 | Sodium acid phosphate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235496 | Sodium acid phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 235496 | Sodium acid phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 235512 | pyridoxine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 235512 | pyridoxine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235524 | Glycyrrhiza glabra root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235524 | Glycyrrhiza glabra root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235534 | polyoxyethylene ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235535 | Carbomer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235535 | Carbomer | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235535 | Carbomer | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235535 | Carbomer | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235535 | Carbomer | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235552 | Ceftazidime pentahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235552 | Ceftazidime pentahydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235552 | Ceftazidime pentahydrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 235552 | Ceftazidime pentahydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235554 | Metacycline hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235554 | Metacycline hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235554 | Metacycline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235554 | Metacycline hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235559 | Nitrofurantoin macrocrystal | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235559 | Nitrofurantoin macrocrystal | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235559 | Nitrofurantoin macrocrystal | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235561 | Nitrofuran derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235561 | Nitrofuran derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235562 | methenamine sulfosalicylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235569 | sulfurated lime | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235577 | sodium phosphate, dibasic 960 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 235577 | sodium phosphate, dibasic 960 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235591 | bran 5000 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2356 | Chlordiazepoxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2356 | Chlordiazepoxide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2356 | Chlordiazepoxide | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2356 | Chlordiazepoxide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2356 | Chlordiazepoxide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2356 | Chlordiazepoxide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 23560 | Deoxyribonucleic acid-deoxyinosine glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23560 | Deoxyribonucleic acid-deoxyinosine glycosidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23560 | Deoxyribonucleic acid-deoxyinosine glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23560 | Deoxyribonucleic acid-deoxyinosine glycosidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235600 | diphtheria toxoid adsorbed | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235608 | iron bile salts 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 235608 | iron bile salts 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235614 | Hymenoptera allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235617 | ceruletide diethylamine 0.02 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235618 | mold extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235636 | estrone 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2357 | Chlorfenvinphos | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2357 | Chlorfenvinphos | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235721 | methapyrilene hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235725 | chlorcyclizine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235726 | isothipendyl hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235737 | amitriptyline pamoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235739 | Prochlorperazine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235739 | Prochlorperazine mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235739 | Prochlorperazine mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235739 | Prochlorperazine mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235742 | Flupentixol dihydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235742 | Flupentixol dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235742 | Flupentixol dihydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235742 | Flupentixol dihydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235743 | Metformin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235743 | Metformin hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235743 | Metformin hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 235743 | Metformin hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235745 | Pipotiazine palmitate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235745 | Pipotiazine palmitate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235745 | Pipotiazine palmitate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235745 | Pipotiazine palmitate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235747 | Pizotifen maleate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235747 | Pizotifen maleate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235747 | Pizotifen maleate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235747 | Pizotifen maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235747 | Pizotifen maleate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235749 | Neomycin B sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235749 | Neomycin B sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235749 | Neomycin B sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235749 | Neomycin B sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235750 | Flucloxacillin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235750 | Flucloxacillin sodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235750 | Flucloxacillin sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235750 | Flucloxacillin sodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235751 | Morphine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235751 | Morphine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235751 | Morphine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235752 | Bepridil hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235752 | Bepridil hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235752 | Bepridil hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235757 | Dapiprazole hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235757 | Dapiprazole hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235757 | Dapiprazole hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235758 | Benazepril hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235758 | Benazepril hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235758 | Benazepril hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235759 | Quinapril hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235759 | Quinapril hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235759 | Quinapril hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235760 | pentobarbital sodium 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235760 | pentobarbital sodium 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 235762 | Lomefloxacin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235762 | Lomefloxacin hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235762 | Lomefloxacin hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235765 | Benserazide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235765 | Benserazide hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235765 | Benserazide hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235766 | Dipipanone hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235766 | Dipipanone hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235767 | bornaprine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235768 | Dopexamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235768 | Dopexamine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235768 | Dopexamine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235770 | Imidamine sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235770 | Imidamine sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235770 | Imidamine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235770 | Imidamine sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235770 | Imidamine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235770 | Imidamine sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235770 | Imidamine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235771 | cyclizine tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235771 | cyclizine tartrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235771 | cyclizine tartrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235773 | Indoramin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235773 | Indoramin hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235773 | Indoramin hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235774 | Morphine tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235774 | Morphine tartrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235774 | Morphine tartrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235775 | pirenzepine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235776 | Potassium hydroxyquinoline sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235776 | Potassium hydroxyquinoline sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235776 | Potassium hydroxyquinoline sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235776 | Potassium hydroxyquinoline sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235776 | Potassium hydroxyquinoline sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235776 | Potassium hydroxyquinoline sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235777 | Prednisolone caproate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235777 | Prednisolone caproate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235778 | Thymoxamine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235778 | Thymoxamine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235778 | Thymoxamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235778 | Thymoxamine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235779 | Trimetazidine dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235779 | Trimetazidine dihydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235779 | Trimetazidine dihydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235779 | Trimetazidine dihydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235782 | Ethylmorphine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235782 | Ethylmorphine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235782 | Ethylmorphine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235784 | calcium lactobionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235784 | calcium lactobionate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235784 | calcium lactobionate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235786 | calcium orotate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235787 | Capsicum oleoresin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 235788 | nicoboxil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235793 | amylocaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2358 | Chlorhexidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2358 | Chlorhexidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2358 | Chlorhexidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2358 | Chlorhexidine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2358 | Chlorhexidine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 23580 | Delta^3^-cis-delta^2^-trans-enoyl-CoA isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23580 | Delta^3^-cis-delta^2^-trans-enoyl-CoA isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23580 | Delta^3^-cis-delta^2^-trans-enoyl-CoA isomerase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23580 | Delta^3^-cis-delta^2^-trans-enoyl-CoA isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23580 | Delta^3^-cis-delta^2^-trans-enoyl-CoA isomerase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235803 | Magnesium glycerophosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235803 | Magnesium glycerophosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235803 | Magnesium glycerophosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235803 | Magnesium glycerophosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235808 | phenicarbazide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235810 | Naphazoline nitrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235810 | Naphazoline nitrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235810 | Naphazoline nitrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235812 | hexylnicotinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235822 | Vitamin K4 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235822 | Vitamin K4 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235822 | Vitamin K4 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235822 | Vitamin K4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235822 | Vitamin K4 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235822 | Vitamin K4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235823 | Aclarubicin hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235823 | Aclarubicin hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2358230 | morphine Injection [Depodur] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 235824 | Azelastine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235824 | Azelastine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235824 | Azelastine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235825 | Flucloxacillin magnesium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235825 | Flucloxacillin magnesium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235825 | Flucloxacillin magnesium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235825 | Flucloxacillin magnesium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235827 | Mebeverine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235827 | Mebeverine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235827 | Mebeverine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235828 | Mecysteine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235828 | Mecysteine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235828 | Mecysteine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235828 | Mecysteine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235828 | Mecysteine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235829 | methoserpidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235830 | Paroxetine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235830 | Paroxetine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235830 | Paroxetine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 235830 | Paroxetine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235831 | prolintane hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235832 | remoxipride hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235833 | reproterol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235836 | talampicillin napsylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235837 | Temocillin sodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235837 | Temocillin sodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235838 | Terbinafine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235838 | Terbinafine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235838 | Terbinafine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235839 | Terodiline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235839 | Terodiline hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235839 | Terodiline hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235840 | Tramazoline hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235840 | Tramazoline hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235841 | tulobuterol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235846 | Loprazolam mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235846 | Loprazolam mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235846 | Loprazolam mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235846 | Loprazolam mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235851 | Ciprofloxacin lactate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235851 | Ciprofloxacin lactate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235851 | Ciprofloxacin lactate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235853 | Lofexidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235853 | Lofexidine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235853 | Lofexidine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235854 | Ofloxacin hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235854 | Ofloxacin hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235855 | trimethoprim lactate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235857 | Melphalan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235857 | Melphalan hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235857 | Melphalan hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235860 | Sodium dibunate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235860 | Sodium dibunate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235860 | Sodium dibunate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235861 | pipoxolan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235862 | Bambuterol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235862 | Bambuterol hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235862 | Bambuterol hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235863 | Magnesium alginate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235863 | Magnesium alginate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235863 | Magnesium alginate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235863 | Magnesium alginate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235874 | Cycletanide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235874 | Cycletanide hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235874 | Cycletanide hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235874 | Cycletanide hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2359 | Chlorhexidine acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2359 | Chlorhexidine acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23591 | Dodecylmercaptan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23591 | Dodecylmercaptan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23591 | Dodecylmercaptan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23591 | Dodecylmercaptan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2359237 | Marboquin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2359238 | marbofloxacin 100 MG [Marboquin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2359239 | marbofloxacin Oral Tablet [Marboquin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359240 | Marboquin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2359241 | Marboquin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2359242 | Marboquin 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359242 | Marboquin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2359242 | Marboquin 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2359243 | marbofloxacin 200 MG [Marboquin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2359244 | Marboquin 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359244 | Marboquin 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2359244 | Marboquin 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2359245 | marbofloxacin 25 MG [Marboquin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2359246 | Marboquin 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359246 | Marboquin 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2359246 | Marboquin 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2359247 | marbofloxacin 50 MG [Marboquin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2359248 | Marboquin 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359248 | Marboquin 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2359248 | Marboquin 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2359249 | dimethicone PEG-8 adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359250 | dimethyl anthranilate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359251 | fenoprop triisopropanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359252 | ecamsule ditriethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359253 | Cedrus deodara seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359254 | chicken cartilage preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359255 | Aloe andongensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359256 | Bacillus amyloliquefaciens | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359257 | 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359258 | 2,2-dinitropropyl acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359259 | 2-(2-(2-hydroxypropoxy)propoxy)-1-propanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359260 | 2-(methylamino)ethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359261 | 3-(2-dodecen-1-yl)dihydro-2,5-furandione, (2E)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359262 | 3-hexenyl salicylate, cis- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359263 | linalool oxide pyranoid, (+/-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359264 | m-aminobenzyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359265 | O-ethylvanillin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359266 | Gastrodia elata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359267 | 1-methyl-2-(phenylmethyl)-4(1H)- quinazolinone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2359267 | 1-methyl-2-(phenylmethyl)-4(1H)- quinazolinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359268 | pemigatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359268 | pemigatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2359268 | pemigatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2359268 | pemigatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2359268 | pemigatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2359269 | Tanacetum annuum flowering top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359270 | Stephania tetrandra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359271 | triethanolamine cacodylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359272 | strawberry seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359273 | propionaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359274 | Prunus speciosa flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359275 | povidone K60 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359276 | empagliflozin / linagliptin / metformin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2359276 | empagliflozin / linagliptin / metformin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359277 | empagliflozin / linagliptin / metformin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2359277 | empagliflozin / linagliptin / metformin Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359278 | empagliflozin / linagliptin / metformin Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2359278 | empagliflozin / linagliptin / metformin Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359279 | empagliflozin 10 MG / linagliptin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359279 | empagliflozin 10 MG / linagliptin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359279 | empagliflozin 10 MG / linagliptin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2359279 | empagliflozin 10 MG / linagliptin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359279 | empagliflozin 10 MG / linagliptin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359280 | Trijardy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2359281 | empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG [Trijardy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2359281 | empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359282 | empagliflozin / linagliptin / metformin Extended Release Oral Tablet [Trijardy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359282 | empagliflozin / linagliptin / metformin Extended Release Oral Tablet [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359283 | Trijardy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2359284 | Trijardy Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2359285 | Trijardy XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359285 | Trijardy XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359285 | Trijardy XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359285 | Trijardy XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359285 | Trijardy XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359286 | empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2359286 | empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2359287 | empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359287 | empagliflozin 10 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2359288 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2359288 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359288 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359288 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359288 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359289 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG [Trijardy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2359289 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359290 | Trijardy XR 12.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359290 | Trijardy XR 12.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359290 | Trijardy XR 12.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359290 | Trijardy XR 12.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359290 | Trijardy XR 12.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359291 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2359291 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2359292 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359292 | empagliflozin 12.5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 235930 | ethoheptazine citrate 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235930 | ethoheptazine citrate 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 235932 | Cibenzoline succinate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235932 | Cibenzoline succinate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235932 | Cibenzoline succinate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235933 | bamethan succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2359330 | pemigatinib 13.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2359331 | pemigatinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2359331 | pemigatinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2359331 | pemigatinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2359332 | pemigatinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2359333 | pemigatinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2359334 | pemigatinib 13.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359334 | pemigatinib 13.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2359334 | pemigatinib 13.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2359334 | pemigatinib 13.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2359335 | Pemazyre | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2359336 | pemigatinib 13.5 MG [Pemazyre] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2359337 | pemigatinib Oral Tablet [Pemazyre] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359338 | Pemazyre Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2359339 | Pemazyre Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 235934 | buflomedil hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2359340 | Pemazyre 13.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359340 | Pemazyre 13.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359340 | Pemazyre 13.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359341 | pemigatinib 4.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2359342 | pemigatinib 4.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359342 | pemigatinib 4.5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2359342 | pemigatinib 4.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2359342 | pemigatinib 4.5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2359343 | pemigatinib 4.5 MG [Pemazyre] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2359344 | Pemazyre 4.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359344 | Pemazyre 4.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359344 | Pemazyre 4.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359345 | pemigatinib 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2359346 | pemigatinib 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359346 | pemigatinib 9 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2359346 | pemigatinib 9 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2359346 | pemigatinib 9 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2359347 | pemigatinib 9 MG [Pemazyre] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2359348 | Pemazyre 9 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359348 | Pemazyre 9 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359348 | Pemazyre 9 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359349 | isopropyl alcohol 0.028 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 235935 | dobesilic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2359350 | ethanol 63.5 % / isopropyl alcohol 2.8 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2359350 | ethanol 63.5 % / isopropyl alcohol 2.8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2359351 | empagliflozin 25 MG / linagliptin 5 MG / metFORMIN hydrochloride 1000 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2359351 | empagliflozin 25 MG / linagliptin 5 MG / metFORMIN hydrochloride 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359351 | empagliflozin 25 MG / linagliptin 5 MG / metFORMIN hydrochloride 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359352 | empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG [Trijardy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2359352 | empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359353 | Trijardy XR 25 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359353 | Trijardy XR 25 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359353 | Trijardy XR 25 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359353 | Trijardy XR 25 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359353 | Trijardy XR 25 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359354 | empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2359354 | empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2359355 | empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359355 | empagliflozin 25 MG / linagliptin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2359356 | empagliflozin 5 MG / linagliptin 2.5 MG / metFORMIN hydrochloride 1000 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2359356 | empagliflozin 5 MG / linagliptin 2.5 MG / metFORMIN hydrochloride 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359356 | empagliflozin 5 MG / linagliptin 2.5 MG / metFORMIN hydrochloride 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359357 | empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG [Trijardy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2359357 | empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359358 | Trijardy XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2359358 | Trijardy XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359358 | Trijardy XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2359358 | Trijardy XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2359358 | Trijardy XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2359359 | empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2359359 | empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2359360 | empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2359360 | empagliflozin 5 MG / linagliptin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Trijardy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2359362 | alpha-lactose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 235940 | artichoke preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235940 | artichoke preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235942 | Butetamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235942 | Butetamate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235942 | Butetamate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235943 | Butetamate citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235943 | Butetamate citrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235943 | Butetamate citrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235945 | aspirin 500 MG / caffeine 32 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235945 | aspirin 500 MG / caffeine 32 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 235945 | aspirin 500 MG / caffeine 32 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235953 | benfluorex hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235954 | bismuth hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235955 | clenbuterol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235956 | clobutinol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235959 | Dihydralazine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235959 | Dihydralazine sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235959 | Dihydralazine sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235959 | Dihydralazine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235960 | Etilefrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235960 | Etilefrine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235960 | Etilefrine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 235961 | fedrilate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235972 | Tacrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235972 | Tacrine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235972 | Tacrine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23598 | 1-dodecylguanidine acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23598 | 1-dodecylguanidine acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23598 | 1-dodecylguanidine acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23598 | 1-dodecylguanidine acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235981 | salicylamide 450 MG / vitamin B12 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 235981 | salicylamide 450 MG / vitamin B12 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 235981 | salicylamide 450 MG / vitamin B12 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235987 | cobalt gluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 235988 | Venlafaxine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235988 | Venlafaxine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 235988 | Venlafaxine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 235991 | anhydrous tacrolimus | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 235992 | zomepirac sodium 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 235992 | zomepirac sodium 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2359930 | Centipeda minima flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359931 | Cirsium arvense flowering top | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359932 | Forsythia suspensa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2359933 | Hericium americanum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 235995 | tinzaparin sodium,porcine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235997 | Tropisetron hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 235997 | Tropisetron hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 235997 | Tropisetron hydrochloride | Full form of descriptor (FN) | NO |